id	sid	tid	token	lemma	pos
dpc-4814	1	1	dermatology	dermatology	NOUN
dpc-4814	1	2	:	:	PUNCT
dpc-4814	1	3	practical	practical	ADJ
dpc-4814	1	4	and	and	CCONJ
dpc-4814	1	5	conceptual	conceptual	ADJ
dpc-4814	1	6	image	image	NOUN
dpc-4814	1	7	letter	letter	NOUN
dpc-4814	2	1	|	|	ADV
dpc-4814	2	2	dermatol	dermatol	ADJ
dpc-4814	2	3	pract	pract	NOUN
dpc-4814	2	4	concept	concept	NOUN
dpc-4814	2	5	.	.	PUNCT
dpc-4814	3	1	2025;15(1):4814	2025;15(1):4814	NUM
dpc-4814	3	2	1	1	NUM
dpc-4814	3	3	combination	combination	NOUN
dpc-4814	3	4	of	of	ADP
dpc-4814	3	5	cemiplimab	cemiplimab	NOUN
dpc-4814	3	6	and	and	CCONJ
dpc-4814	3	7	radiotherapy	radiotherapy	NOUN
dpc-4814	3	8	in	in	ADP
dpc-4814	3	9	advanced	advanced	ADJ
dpc-4814	3	10	squamous	squamous	ADJ
dpc-4814	3	11	cell	cell	NOUN
dpc-4814	3	12	carcinoma	carcinoma	NOUN
dpc-4814	3	13	andré	andré	PROPN
dpc-4814	3	14	aparício	aparício	PROPN
dpc-4814	3	15	martins1	martins1	PROPN
dpc-4814	3	16	,	,	PUNCT
dpc-4814	3	17	joão	joão	PROPN
dpc-4814	3	18	teixeira1	teixeira1	PROPN
dpc-4814	3	19	,	,	PUNCT
dpc-4814	3	20	ricardo	ricardo	PROPN
dpc-4814	3	21	vieira1	vieira1	PROPN
dpc-4814	3	22	,	,	PUNCT
dpc-4814	3	23	inês	inês	ADJ
dpc-4814	3	24	coutinho1	coutinho1	NOUN
dpc-4814	3	25	1	1	NUM
dpc-4814	3	26	dermatology	dermatology	NOUN
dpc-4814	3	27	and	and	CCONJ
dpc-4814	3	28	venereology	venereology	NOUN
dpc-4814	3	29	department	department	NOUN
dpc-4814	3	30	,	,	PUNCT
dpc-4814	3	31	unidade	unidade	ADJ
dpc-4814	3	32	local	local	ADJ
dpc-4814	3	33	de	de	X
dpc-4814	3	34	saúde	saúde	PROPN
dpc-4814	3	35	de	de	X
dpc-4814	3	36	coimbra	coimbra	PROPN
dpc-4814	3	37	,	,	PUNCT
dpc-4814	3	38	coimbra	coimbra	PROPN
dpc-4814	3	39	,	,	PUNCT
dpc-4814	3	40	portugal	portugal	PROPN
dpc-4814	3	41	citation	citation	NOUN
dpc-4814	3	42	:	:	PUNCT
dpc-4814	3	43	aparício	aparício	NOUN
dpc-4814	3	44	martins	martin	VERB
dpc-4814	3	45	a	a	PRON
dpc-4814	3	46	,	,	PUNCT
dpc-4814	3	47	teixeira	teixeira	PROPN
dpc-4814	3	48	j	j	PROPN
dpc-4814	3	49	,	,	PUNCT
dpc-4814	3	50	vieira	vieira	PROPN
dpc-4814	3	51	r	r	PROPN
dpc-4814	3	52	,	,	PUNCT
dpc-4814	3	53	coutinho	coutinho	PROPN
dpc-4814	3	54	i.	i.	PROPN
dpc-4814	3	55	combination	combination	NOUN
dpc-4814	3	56	of	of	ADP
dpc-4814	3	57	cemiplimab	cemiplimab	NOUN
dpc-4814	3	58	and	and	CCONJ
dpc-4814	3	59	radiotherapy	radiotherapy	NOUN
dpc-4814	3	60	in	in	ADP
dpc-4814	3	61	advanced	advanced	ADJ
dpc-4814	3	62	squamous	squamous	ADJ
dpc-4814	3	63	cell	cell	NOUN
dpc-4814	3	64	carcinoma	carcinoma	NOUN
dpc-4814	3	65	.	.	PUNCT
dpc-4814	4	1	dermatol	dermatol	NOUN
dpc-4814	4	2	pract	pract	PROPN
dpc-4814	4	3	concept	concept	NOUN
dpc-4814	4	4	.	.	PUNCT
dpc-4814	5	1	2025;15(1):4814	2025;15(1):4814	NUM
dpc-4814	5	2	.	.	PUNCT
dpc-4814	6	1	doi	doi	PROPN
dpc-4814	6	2	:	:	PUNCT
dpc-4814	6	3	https://doi.org/10.5826/dpc.1501a4814	https://doi.org/10.5826/dpc.1501a4814	PROPN
dpc-4814	6	4	accepted	accept	VERB
dpc-4814	6	5	:	:	PUNCT
dpc-4814	6	6	november	november	PROPN
dpc-4814	6	7	9	9	NUM
dpc-4814	6	8	,	,	PUNCT
dpc-4814	6	9	2024	2024	NUM
dpc-4814	6	10	;	;	PUNCT
dpc-4814	6	11	published	publish	VERB
dpc-4814	6	12	:	:	PUNCT
dpc-4814	7	1	january	january	PROPN
dpc-4814	7	2	2025	2025	NUM
dpc-4814	7	3	copyright	copyright	NOUN
dpc-4814	7	4	:	:	PUNCT
dpc-4814	7	5	©	©	PROPN
dpc-4814	7	6	aparício	aparício	NOUN
dpc-4814	7	7	martins	martin	VERB
dpc-4814	7	8	et	et	NOUN
dpc-4814	7	9	al	al	PROPN
dpc-4814	7	10	.	.	PUNCT
dpc-4814	8	1	this	this	PRON
dpc-4814	8	2	is	be	AUX
dpc-4814	8	3	an	an	DET
dpc-4814	8	4	open	open	ADJ
dpc-4814	8	5	-	-	PUNCT
dpc-4814	8	6	access	access	NOUN
dpc-4814	8	7	article	article	NOUN
dpc-4814	8	8	distributed	distribute	VERB
dpc-4814	8	9	under	under	ADP
dpc-4814	8	10	the	the	DET
dpc-4814	8	11	terms	term	NOUN
dpc-4814	8	12	of	of	ADP
dpc-4814	8	13	the	the	DET
dpc-4814	8	14	creative	creative	ADJ
dpc-4814	8	15	commons	common	NOUN
dpc-4814	8	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4814	8	17	license	license	NOUN
dpc-4814	8	18	(	(	PUNCT
dpc-4814	8	19	by	by	ADP
dpc-4814	8	20	-	-	PUNCT
dpc-4814	8	21	nc-4.0	nc-4.0	NOUN
dpc-4814	8	22	)	)	PUNCT
dpc-4814	8	23	,	,	PUNCT
dpc-4814	8	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4814	8	25	,	,	PUNCT
dpc-4814	8	26	which	which	PRON
dpc-4814	8	27	permits	permit	VERB
dpc-4814	8	28	unrestricted	unrestricted	ADJ
dpc-4814	8	29	noncommercial	noncommercial	ADJ
dpc-4814	8	30	use	use	NOUN
dpc-4814	8	31	,	,	PUNCT
dpc-4814	8	32	distribution	distribution	NOUN
dpc-4814	8	33	,	,	PUNCT
dpc-4814	8	34	and	and	CCONJ
dpc-4814	8	35	reproduction	reproduction	NOUN
dpc-4814	8	36	in	in	ADP
dpc-4814	8	37	any	any	DET
dpc-4814	8	38	medium	medium	NOUN
dpc-4814	8	39	,	,	PUNCT
dpc-4814	8	40	provided	provide	VERB
dpc-4814	8	41	the	the	DET
dpc-4814	8	42	original	original	ADJ
dpc-4814	8	43	authors	author	NOUN
dpc-4814	8	44	and	and	CCONJ
dpc-4814	8	45	source	source	NOUN
dpc-4814	8	46	are	be	AUX
dpc-4814	8	47	credited	credit	VERB
dpc-4814	8	48	.	.	PUNCT
dpc-4814	9	1	funding	funding	NOUN
dpc-4814	9	2	:	:	PUNCT
dpc-4814	9	3	none	none	NOUN
dpc-4814	9	4	.	.	PUNCT
dpc-4814	10	1	competing	compete	VERB
dpc-4814	10	2	interests	interest	NOUN
dpc-4814	10	3	:	:	PUNCT
dpc-4814	10	4	none	none	NOUN
dpc-4814	10	5	.	.	PUNCT
dpc-4814	11	1	authorship	authorship	NOUN
dpc-4814	11	2	:	:	PUNCT
dpc-4814	11	3	all	all	DET
dpc-4814	11	4	authors	author	NOUN
dpc-4814	11	5	have	have	AUX
dpc-4814	11	6	contributed	contribute	VERB
dpc-4814	11	7	significantly	significantly	ADV
dpc-4814	11	8	to	to	ADP
dpc-4814	11	9	this	this	DET
dpc-4814	11	10	publication	publication	NOUN
dpc-4814	11	11	.	.	PUNCT
dpc-4814	12	1	corresponding	correspond	VERB
dpc-4814	12	2	author	author	NOUN
dpc-4814	12	3	:	:	PUNCT
dpc-4814	12	4	andré	andré	PROPN
dpc-4814	12	5	aparício	aparício	NOUN
dpc-4814	12	6	martins	martin	NOUN
dpc-4814	12	7	,	,	PUNCT
dpc-4814	12	8	dermatology	dermatology	NOUN
dpc-4814	12	9	and	and	CCONJ
dpc-4814	12	10	venereology	venereology	NOUN
dpc-4814	12	11	department	department	NOUN
dpc-4814	12	12	,	,	PUNCT
dpc-4814	12	13	unidade	unidade	ADJ
dpc-4814	12	14	local	local	ADJ
dpc-4814	12	15	de	de	X
dpc-4814	12	16	saúde	saúde	PROPN
dpc-4814	12	17	de	de	X
dpc-4814	12	18	coimbra	coimbra	PROPN
dpc-4814	12	19	,	,	PUNCT
dpc-4814	12	20	coimbra	coimbra	PROPN
dpc-4814	12	21	,	,	PUNCT
dpc-4814	12	22	portugal	portugal	PROPN
dpc-4814	12	23	,	,	PUNCT
dpc-4814	12	24	praceta	praceta	NOUN
dpc-4814	12	25	prof	prof	NOUN
dpc-4814	12	26	.	.	PUNCT
dpc-4814	13	1	mota	mota	PROPN
dpc-4814	13	2	pinto	pinto	NOUN
dpc-4814	13	3	3004	3004	NUM
dpc-4814	13	4	-	-	SYM
dpc-4814	13	5	561	561	NUM
dpc-4814	13	6	coimbra	coimbra	NOUN
dpc-4814	13	7	,	,	PUNCT
dpc-4814	13	8	portugal	portugal	PROPN
dpc-4814	13	9	.	.	PUNCT
dpc-4814	14	1	e	e	X
dpc-4814	14	2	-	-	NOUN
dpc-4814	14	3	mail	mail	NOUN
dpc-4814	14	4	:	:	PUNCT
dpc-4814	14	5	andre.aparicio92@hotmail.com	andre.aparicio92@hotmail.com	X
dpc-4814	14	6	case	case	NOUN
dpc-4814	14	7	presentation	presentation	NOUN
dpc-4814	14	8	a	a	DET
dpc-4814	14	9	69	69	NUM
dpc-4814	14	10	-	-	PUNCT
dpc-4814	14	11	year	year	NOUN
dpc-4814	14	12	-	-	PUNCT
dpc-4814	14	13	old	old	ADJ
dpc-4814	14	14	man	man	NOUN
dpc-4814	14	15	presented	present	VERB
dpc-4814	14	16	with	with	ADP
dpc-4814	14	17	a	a	DET
dpc-4814	14	18	loco	loco	NOUN
dpc-4814	14	19	-	-	PUNCT
dpc-4814	14	20	regional	regional	ADJ
dpc-4814	14	21	recurrence	recurrence	NOUN
dpc-4814	14	22	of	of	ADP
dpc-4814	14	23	a	a	DET
dpc-4814	14	24	squamous	squamous	ADJ
dpc-4814	14	25	cell	cell	NOUN
dpc-4814	14	26	carcinoma	carcinoma	NOUN
dpc-4814	14	27	(	(	PUNCT
dpc-4814	14	28	scc	scc	NOUN
dpc-4814	14	29	)	)	PUNCT
dpc-4814	14	30	of	of	ADP
dpc-4814	14	31	the	the	DET
dpc-4814	14	32	left	left	ADJ
dpc-4814	14	33	auricle	auricle	NOUN
dpc-4814	14	34	,	,	PUNCT
dpc-4814	14	35	8	8	NUM
dpc-4814	14	36	months	month	NOUN
dpc-4814	14	37	after	after	ADP
dpc-4814	14	38	complete	complete	ADJ
dpc-4814	14	39	excision	excision	NOUN
dpc-4814	14	40	.	.	PUNCT
dpc-4814	15	1	the	the	DET
dpc-4814	15	2	pet	pet	NOUN
dpc-4814	15	3	/	/	SYM
dpc-4814	15	4	ct	ct	PROPN
dpc-4814	15	5	scan	scan	PROPN
dpc-4814	15	6	confirmed	confirm	VERB
dpc-4814	15	7	the	the	DET
dpc-4814	15	8	local	local	ADJ
dpc-4814	15	9	recurrence	recurrence	NOUN
dpc-4814	15	10	,	,	PUNCT
dpc-4814	15	11	extending	extend	VERB
dpc-4814	15	12	from	from	ADP
dpc-4814	15	13	the	the	DET
dpc-4814	15	14	auricle	auricle	NOUN
dpc-4814	15	15	to	to	ADP
dpc-4814	15	16	the	the	DET
dpc-4814	15	17	inferior	inferior	ADJ
dpc-4814	15	18	edge	edge	NOUN
dpc-4814	15	19	of	of	ADP
dpc-4814	15	20	mandibula	mandibula	NOUN
dpc-4814	15	21	,	,	PUNCT
dpc-4814	15	22	invading	invade	VERB
dpc-4814	15	23	the	the	DET
dpc-4814	15	24	parotid	parotid	ADJ
dpc-4814	15	25	gland	gland	NOUN
dpc-4814	15	26	,	,	PUNCT
dpc-4814	15	27	with	with	ADP
dpc-4814	15	28	extensive	extensive	ADJ
dpc-4814	15	29	cervical	cervical	ADJ
dpc-4814	15	30	lymph	lymph	NOUN
dpc-4814	15	31	node	node	NOUN
dpc-4814	15	32	involvement	involvement	NOUN
dpc-4814	15	33	.	.	PUNCT
dpc-4814	16	1	disease	disease	NOUN
dpc-4814	16	2	was	be	AUX
dpc-4814	16	3	not	not	PART
dpc-4814	16	4	amenable	amenable	ADJ
dpc-4814	16	5	to	to	ADP
dpc-4814	16	6	surgery	surgery	NOUN
dpc-4814	16	7	and	and	CCONJ
dpc-4814	16	8	immunotherapy	immunotherapy	NOUN
dpc-4814	16	9	with	with	ADP
dpc-4814	16	10	cemiplimab	cemiplimab	NOUN
dpc-4814	16	11	350	350	NUM
dpc-4814	16	12	mg	mg	NOUN
dpc-4814	16	13	every	every	DET
dpc-4814	16	14	3	3	NUM
dpc-4814	16	15	weeks	week	NOUN
dpc-4814	16	16	was	be	AUX
dpc-4814	16	17	started	start	VERB
dpc-4814	16	18	.	.	PUNCT
dpc-4814	17	1	during	during	ADP
dpc-4814	17	2	2	2	NUM
dpc-4814	17	3	treatment	treatment	NOUN
dpc-4814	17	4	cycles	cycle	NOUN
dpc-4814	17	5	,	,	PUNCT
dpc-4814	17	6	significant	significant	ADJ
dpc-4814	17	7	tumor	tumor	NOUN
dpc-4814	17	8	enlargement	enlargement	NOUN
dpc-4814	17	9	was	be	AUX
dpc-4814	17	10	observed	observe	VERB
dpc-4814	17	11	,	,	PUNCT
dpc-4814	17	12	with	with	ADP
dpc-4814	17	13	increasing	increase	VERB
dpc-4814	17	14	local	local	ADJ
dpc-4814	17	15	pain	pain	NOUN
dpc-4814	17	16	,	,	PUNCT
dpc-4814	17	17	dysphagia	dysphagia	PROPN
dpc-4814	17	18	,	,	PUNCT
dpc-4814	17	19	left	leave	VERB
dpc-4814	17	20	facial	facial	ADJ
dpc-4814	17	21	paralysis	paralysis	NOUN
dpc-4814	17	22	and	and	CCONJ
dpc-4814	17	23	massive	massive	ADJ
dpc-4814	17	24	local	local	ADJ
dpc-4814	17	25	hemorrhage	hemorrhage	NOUN
dpc-4814	17	26	episodes	episode	NOUN
dpc-4814	17	27	(	(	PUNCT
dpc-4814	17	28	figure	figure	NOUN
dpc-4814	17	29	1	1	NUM
dpc-4814	17	30	a	a	NOUN
dpc-4814	17	31	)	)	PUNCT
dpc-4814	17	32	.	.	PUNCT
dpc-4814	18	1	hemostatic	hemostatic	ADJ
dpc-4814	18	2	radiotherapy	radiotherapy	NOUN
dpc-4814	18	3	(	(	PUNCT
dpc-4814	18	4	20	20	NUM
dpc-4814	18	5	gy	gy	NOUN
dpc-4814	18	6	in	in	ADP
dpc-4814	18	7	5	5	NUM
dpc-4814	18	8	fractions	fraction	NOUN
dpc-4814	18	9	)	)	PUNCT
dpc-4814	18	10	was	be	AUX
dpc-4814	18	11	proposed	propose	VERB
dpc-4814	18	12	,	,	PUNCT
dpc-4814	18	13	with	with	ADP
dpc-4814	18	14	significant	significant	ADJ
dpc-4814	18	15	response	response	NOUN
dpc-4814	18	16	in	in	ADP
dpc-4814	18	17	3	3	NUM
dpc-4814	18	18	weeks	week	NOUN
dpc-4814	18	19	.	.	PUNCT
dpc-4814	19	1	on	on	ADP
dpc-4814	19	2	the	the	DET
dpc-4814	19	3	third	third	ADJ
dpc-4814	19	4	cycle	cycle	NOUN
dpc-4814	19	5	of	of	ADP
dpc-4814	19	6	cemiplimab	cemiplimab	NOUN
dpc-4814	19	7	,	,	PUNCT
dpc-4814	19	8	the	the	DET
dpc-4814	19	9	patient	patient	NOUN
dpc-4814	19	10	was	be	AUX
dpc-4814	19	11	asymptomatic	asymptomatic	ADJ
dpc-4814	19	12	with	with	ADP
dpc-4814	19	13	only	only	ADV
dpc-4814	19	14	a	a	DET
dpc-4814	19	15	crusted	crust	VERB
dpc-4814	19	16	plaque	plaque	NOUN
dpc-4814	19	17	on	on	ADP
dpc-4814	19	18	physical	physical	ADJ
dpc-4814	19	19	examination	examination	NOUN
dpc-4814	19	20	(	(	PUNCT
dpc-4814	19	21	figure	figure	NOUN
dpc-4814	19	22	1	1	NUM
dpc-4814	19	23	b	b	NOUN
dpc-4814	19	24	)	)	PUNCT
dpc-4814	19	25	.	.	PUNCT
dpc-4814	20	1	at	at	ADP
dpc-4814	20	2	the	the	DET
dpc-4814	20	3	12	12	NUM
dpc-4814	20	4	-	-	PUNCT
dpc-4814	20	5	week	week	NOUN
dpc-4814	20	6	follow	follow	NOUN
dpc-4814	20	7	-	-	PUNCT
dpc-4814	20	8	up	up	NOUN
dpc-4814	20	9	,	,	PUNCT
dpc-4814	20	10	ct	ct	PROPN
dpc-4814	20	11	scan	scan	PROPN
dpc-4814	20	12	showed	show	VERB
dpc-4814	20	13	an	an	DET
dpc-4814	20	14	unspecific	unspecific	ADJ
dpc-4814	20	15	post	post	ADJ
dpc-4814	20	16	-	-	ADJ
dpc-4814	20	17	therapeutic	therapeutic	ADJ
dpc-4814	20	18	tissue	tissue	NOUN
dpc-4814	20	19	densification	densification	NOUN
dpc-4814	20	20	near	near	ADP
dpc-4814	20	21	left	left	ADJ
dpc-4814	20	22	auricle	auricle	NOUN
dpc-4814	20	23	,	,	PUNCT
dpc-4814	20	24	without	without	ADP
dpc-4814	20	25	cervical	cervical	ADJ
dpc-4814	20	26	adenopathies	adenopathy	NOUN
dpc-4814	20	27	,	,	PUNCT
dpc-4814	20	28	suggestive	suggestive	ADJ
dpc-4814	20	29	of	of	ADP
dpc-4814	20	30	complete	complete	ADJ
dpc-4814	20	31	response	response	NOUN
dpc-4814	20	32	.	.	PUNCT
dpc-4814	21	1	teaching	teaching	NOUN
dpc-4814	21	2	point	point	NOUN
dpc-4814	21	3	low	low	ADJ
dpc-4814	21	4	doses	dose	NOUN
dpc-4814	21	5	(	(	PUNCT
dpc-4814	21	6	2	2	NUM
dpc-4814	21	7	-	-	SYM
dpc-4814	21	8	25	25	NUM
dpc-4814	21	9	gy	gy	NOUN
dpc-4814	21	10	)	)	PUNCT
dpc-4814	21	11	of	of	ADP
dpc-4814	21	12	hypofractionated	hypofractionate	VERB
dpc-4814	21	13	radiation	radiation	NOUN
dpc-4814	21	14	therapy	therapy	NOUN
dpc-4814	21	15	can	can	AUX
dpc-4814	21	16	modulate	modulate	VERB
dpc-4814	21	17	immune	immune	ADJ
dpc-4814	21	18	cells	cell	NOUN
dpc-4814	21	19	and	and	CCONJ
dpc-4814	21	20	cause	cause	VERB
dpc-4814	21	21	pd-1	pd-1	ADJ
dpc-4814	21	22	overexpression	overexpression	NOUN
dpc-4814	21	23	in	in	ADP
dpc-4814	21	24	tumoral	tumoral	ADJ
dpc-4814	21	25	micro	micro	NOUN
dpc-4814	21	26	-	-	NOUN
dpc-4814	21	27	environment	environment	NOUN
dpc-4814	21	28	[	[	X
dpc-4814	21	29	1	1	NUM
dpc-4814	21	30	]	]	PUNCT
dpc-4814	21	31	.	.	PUNCT
dpc-4814	22	1	these	these	DET
dpc-4814	22	2	immunomodulatory	immunomodulatory	ADJ
dpc-4814	22	3	mechanisms	mechanism	NOUN
dpc-4814	22	4	can	can	AUX
dpc-4814	22	5	be	be	AUX
dpc-4814	22	6	synergistic	synergistic	ADJ
dpc-4814	22	7	with	with	ADP
dpc-4814	22	8	immunotherapy	immunotherapy	NOUN
dpc-4814	22	9	,	,	PUNCT
dpc-4814	22	10	leading	lead	VERB
dpc-4814	22	11	to	to	ADP
dpc-4814	22	12	a	a	DET
dpc-4814	22	13	quicker	quick	ADJ
dpc-4814	22	14	and	and	CCONJ
dpc-4814	22	15	persistent	persistent	ADJ
dpc-4814	22	16	clinico	clinico	NOUN
dpc-4814	22	17	-	-	PUNCT
dpc-4814	22	18	radiological	radiological	ADJ
dpc-4814	22	19	response	response	NOUN
dpc-4814	22	20	,	,	PUNCT
dpc-4814	22	21	with	with	ADP
dpc-4814	22	22	prolonged	prolonged	ADJ
dpc-4814	22	23	progression	progression	NOUN
dpc-4814	22	24	-	-	PUNCT
dpc-4814	22	25	free	free	ADJ
dpc-4814	22	26	survival	survival	NOUN
dpc-4814	22	27	[	[	X
dpc-4814	22	28	2	2	NUM
dpc-4814	22	29	]	]	PUNCT
dpc-4814	22	30	.	.	PUNCT
dpc-4814	23	1	in	in	ADP
dpc-4814	23	2	this	this	DET
dpc-4814	23	3	patient	patient	NOUN
dpc-4814	23	4	,	,	PUNCT
dpc-4814	23	5	tumor	tumor	NOUN
dpc-4814	23	6	enlargement	enlargement	NOUN
dpc-4814	23	7	after	after	ADP
dpc-4814	23	8	2	2	NUM
dpc-4814	23	9	cycles	cycle	NOUN
dpc-4814	23	10	of	of	ADP
dpc-4814	23	11	cemiplimab	cemiplimab	NOUN
dpc-4814	23	12	,	,	PUNCT
dpc-4814	23	13	may	may	AUX
dpc-4814	23	14	correspond	correspond	VERB
dpc-4814	23	15	to	to	ADP
dpc-4814	23	16	pseudo	pseudo	NOUN
dpc-4814	23	17	-	-	NOUN
dpc-4814	23	18	progression	progression	NOUN
dpc-4814	23	19	.	.	PUNCT
dpc-4814	24	1	however	however	ADV
dpc-4814	24	2	,	,	PUNCT
dpc-4814	24	3	impressive	impressive	ADJ
dpc-4814	24	4	tumor	tumor	NOUN
dpc-4814	24	5	growth	growth	NOUN
dpc-4814	24	6	,	,	PUNCT
dpc-4814	24	7	namely	namely	ADV
dpc-4814	24	8	with	with	ADP
dpc-4814	24	9	severe	severe	ADJ
dpc-4814	24	10	hemorrhage	hemorrhage	NOUN
dpc-4814	24	11	,	,	PUNCT
dpc-4814	24	12	indicated	indicate	VERB
dpc-4814	24	13	the	the	DET
dpc-4814	24	14	choice	choice	NOUN
dpc-4814	24	15	for	for	ADP
dpc-4814	24	16	hemostatic	hemostatic	ADJ
dpc-4814	24	17	low	low	ADJ
dpc-4814	24	18	-	-	PUNCT
dpc-4814	24	19	dose	dose	NOUN
dpc-4814	24	20	radiotherapy	radiotherapy	NOUN
dpc-4814	24	21	.	.	PUNCT
dpc-4814	25	1	subsequent	subsequent	ADJ
dpc-4814	25	2	clinical	clinical	ADJ
dpc-4814	25	3	evolution	evolution	NOUN
dpc-4814	25	4	was	be	AUX
dpc-4814	25	5	impressive	impressive	ADJ
dpc-4814	25	6	,	,	PUNCT
dpc-4814	25	7	illustrating	illustrate	VERB
dpc-4814	25	8	an	an	DET
dpc-4814	25	9	enhanced	enhanced	ADJ
dpc-4814	25	10	response	response	NOUN
dpc-4814	25	11	,	,	PUNCT
dpc-4814	25	12	caused	cause	VERB
dpc-4814	25	13	by	by	ADP
dpc-4814	25	14	combination	combination	NOUN
dpc-4814	25	15	of	of	ADP
dpc-4814	25	16	immunotherapy	immunotherapy	NOUN
dpc-4814	25	17	and	and	CCONJ
dpc-4814	25	18	low	low	ADJ
dpc-4814	25	19	-	-	PUNCT
dpc-4814	25	20	dose	dose	NOUN
dpc-4814	25	21	radiotherapy	radiotherapy	NOUN
dpc-4814	25	22	.	.	PUNCT
dpc-4814	26	1	this	this	DET
dpc-4814	26	2	therapeutic	therapeutic	ADJ
dpc-4814	26	3	approach	approach	NOUN
dpc-4814	26	4	should	should	AUX
dpc-4814	26	5	be	be	AUX
dpc-4814	26	6	considered	consider	VERB
dpc-4814	26	7	in	in	ADP
dpc-4814	26	8	challenging	challenging	ADJ
dpc-4814	26	9	cases	case	NOUN
dpc-4814	26	10	of	of	ADP
dpc-4814	26	11	advanced	advanced	ADJ
dpc-4814	26	12	scc	scc	NOUN
dpc-4814	26	13	,	,	PUNCT
dpc-4814	26	14	as	as	ADP
dpc-4814	26	15	in	in	ADP
dpc-4814	26	16	bulky	bulky	ADJ
dpc-4814	26	17	disease	disease	NOUN
dpc-4814	26	18	,	,	PUNCT
dpc-4814	26	19	or	or	CCONJ
dpc-4814	26	20	in	in	ADP
dpc-4814	26	21	extremely	extremely	ADV
dpc-4814	26	22	symptomatic	symptomatic	ADJ
dpc-4814	26	23	patients	patient	NOUN
dpc-4814	26	24	.	.	PUNCT
dpc-4814	27	1	2	2	NUM
dpc-4814	27	2	image	image	NOUN
dpc-4814	27	3	letter	letter	NOUN
dpc-4814	27	4	|	|	ADV
dpc-4814	27	5	dermatol	dermatol	ADJ
dpc-4814	27	6	pract	pract	NOUN
dpc-4814	27	7	concept	concept	NOUN
dpc-4814	27	8	.	.	PUNCT
dpc-4814	28	1	2025;15(1):4814	2025;15(1):4814	NUM
dpc-4814	28	2	2	2	NUM
dpc-4814	28	3	.	.	PUNCT
dpc-4814	28	4	joseph	joseph	PROPN
dpc-4814	28	5	k	k	PROPN
dpc-4814	28	6	,	,	PUNCT
dpc-4814	28	7	walker	walker	PROPN
dpc-4814	28	8	j	j	PROPN
dpc-4814	28	9	,	,	PUNCT
dpc-4814	28	10	raziee	raziee	PROPN
dpc-4814	28	11	h	h	PROPN
dpc-4814	28	12	,	,	PUNCT
dpc-4814	28	13	faruqi	faruqi	PROPN
dpc-4814	28	14	s	s	PART
dpc-4814	28	15	,	,	PUNCT
dpc-4814	28	16	smylie	smylie	ADJ
dpc-4814	28	17	m.	m.	NOUN
dpc-4814	28	18	pd-1	pd-1	ADP
dpc-4814	28	19	blockade	blockade	NOUN
dpc-4814	28	20	with	with	ADP
dpc-4814	28	21	concurrent	concurrent	ADJ
dpc-4814	28	22	radiotherapy	radiotherapy	NOUN
dpc-4814	28	23	for	for	ADP
dpc-4814	28	24	locally	locally	ADV
dpc-4814	28	25	advanced	advanced	ADJ
dpc-4814	28	26	inoperable	inoperable	ADJ
dpc-4814	28	27	cutaneous	cutaneous	ADJ
dpc-4814	28	28	squamous	squamous	ADJ
dpc-4814	28	29	cell	cell	NOUN
dpc-4814	28	30	carcinoma	carcinoma	NOUN
dpc-4814	28	31	.	.	PUNCT
dpc-4814	29	1	j	j	PROPN
dpc-4814	29	2	cutan	cutan	PROPN
dpc-4814	29	3	med	med	PROPN
dpc-4814	29	4	surg	surg	NOUN
dpc-4814	29	5	.	.	PUNCT
dpc-4814	30	1	2022;26(3):243	2022;26(3):243	NUM
dpc-4814	30	2	-	-	PUNCT
dpc-4814	30	3	248	248	NUM
dpc-4814	30	4	.	.	PUNCT
dpc-4814	31	1	doi:10.1177/12034754211064273	doi:10.1177/12034754211064273	NOUN
dpc-4814	31	2	.	.	PUNCT
dpc-4814	32	1	pmid	pmid	NOUN
dpc-4814	32	2	:	:	PUNCT
dpc-4814	32	3	34866423	34866423	NUM
dpc-4814	32	4	.	.	PUNCT
dpc-4814	33	1	references	reference	NOUN
dpc-4814	33	2	1	1	NUM
dpc-4814	33	3	.	.	PUNCT
dpc-4814	34	1	kumari	kumari	PROPN
dpc-4814	34	2	a	a	PROPN
dpc-4814	34	3	,	,	PUNCT
dpc-4814	34	4	simon	simon	PROPN
dpc-4814	34	5	ss	ss	PROPN
dpc-4814	34	6	,	,	PUNCT
dpc-4814	34	7	moody	moody	ADJ
dpc-4814	34	8	td	td	NOUN
dpc-4814	34	9	,	,	PUNCT
dpc-4814	34	10	garnett	garnett	PROPN
dpc-4814	34	11	-	-	PUNCT
dpc-4814	34	12	benson	benson	PROPN
dpc-4814	34	13	c.	c.	PROPN
dpc-4814	34	14	immunomodulatory	immunomodulatory	PROPN
dpc-4814	34	15	effects	effect	NOUN
dpc-4814	34	16	of	of	ADP
dpc-4814	34	17	radiation	radiation	NOUN
dpc-4814	34	18	:	:	PUNCT
dpc-4814	34	19	what	what	PRON
dpc-4814	34	20	is	be	AUX
dpc-4814	34	21	next	next	ADJ
dpc-4814	34	22	for	for	ADP
dpc-4814	34	23	cancer	cancer	NOUN
dpc-4814	34	24	therapy	therapy	NOUN
dpc-4814	34	25	?	?	PUNCT
dpc-4814	35	1	future	future	ADJ
dpc-4814	35	2	oncol	oncol	ADJ
dpc-4814	35	3	.	.	PUNCT
dpc-4814	36	1	2016;12(2):239	2016;12(2):239	NUM
dpc-4814	36	2	-	-	SYM
dpc-4814	36	3	256	256	NUM
dpc-4814	36	4	.	.	PUNCT
dpc-4814	36	5	doi:10.2217	doi:10.2217	NOUN
dpc-4814	36	6	/	/	SYM
dpc-4814	36	7	fon.15.300	fon.15.300	NOUN
dpc-4814	36	8	.	.	PUNCT
dpc-4814	37	1	pmid	pmid	NOUN
dpc-4814	37	2	:	:	PUNCT
dpc-4814	37	3	26621553	26621553	NUM
dpc-4814	37	4	.	.	PUNCT
dpc-4814	38	1	pmcid	pmcid	NOUN
dpc-4814	38	2	:	:	PUNCT
dpc-4814	38	3	pmc5479357	pmc5479357	VERB
dpc-4814	38	4	.	.	PUNCT
dpc-4814	39	1	figure	figure	NOUN
dpc-4814	39	2	1	1	NUM
dpc-4814	39	3	.	.	PUNCT
dpc-4814	40	1	(	(	PUNCT
dpc-4814	40	2	a	a	X
dpc-4814	40	3	)	)	PUNCT
dpc-4814	40	4	our	our	PRON
dpc-4814	40	5	patient	patient	ADJ
dpc-4814	40	6	squamous	squamous	ADJ
dpc-4814	40	7	cell	cell	NOUN
dpc-4814	40	8	carcinoma	carcinoma	NOUN
dpc-4814	40	9	after	after	ADP
dpc-4814	40	10	2	2	NUM
dpc-4814	40	11	cycles	cycle	NOUN
dpc-4814	40	12	of	of	ADP
dpc-4814	40	13	cemiplimab	cemiplimab	NOUN
dpc-4814	40	14	and	and	CCONJ
dpc-4814	40	15	(	(	PUNCT
dpc-4814	40	16	b	b	X
dpc-4814	40	17	)	)	PUNCT
dpc-4814	40	18	its	its	PRON
dpc-4814	40	19	regression	regression	NOUN
dpc-4814	40	20	after	after	ADP
dpc-4814	40	21	hemostatic	hemostatic	ADJ
dpc-4814	40	22	low	low	ADJ
dpc-4814	40	23	-	-	PUNCT
dpc-4814	40	24	dose	dose	NOUN
dpc-4814	40	25	radiotherapy	radiotherapy	NOUN
dpc-4814	40	26	and	and	CCONJ
dpc-4814	40	27	3	3	NUM
dpc-4814	40	28	cycles	cycle	NOUN
dpc-4814	40	29	of	of	ADP
dpc-4814	40	30	cemiplimab	cemiplimab	NOUN
dpc-4814	40	31	.	.	PUNCT